| 发明名称 |
Method Of Achieving Increased Systemic Availability of Methotrexate |
| 摘要 |
Determining that a patient in need of methotrexate requires more systemically available methotrexate than can be obtained by an orally administered dose of methotrexate; and subcutaneously administering a dose of methotrexate to the patient. |
| 申请公布号 |
US2015297600(A1) |
申请公布日期 |
2015.10.22 |
| 申请号 |
US201514688061 |
申请日期 |
2015.04.16 |
| 申请人 |
Antares Pharma, Inc. |
发明人 |
SADOWSKI Peter L.;DAVE Kaushik J.;WOTTON Paul K.;JOOSTE Hermanus L. |
| 分类号 |
A61K31/519;A61M5/00 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of achieving increased systemic availability of methotrexate comprising:
(a) determining that a patient in need of methotrexate requires more systemically available methotrexate than can be obtained by an orally administered dose of methotrexate; and, (b) subcutaneously administering a dose of methotrexate which provides more systemically available methotrexate than could be obtained by the orally administered dose of methotrexate. |
| 地址 |
Ewing NJ US |
